Polo-like kinase 1 may regulate G2/M transition of mouse fertilized eggs by means of inhibiting the phosphorylation of Tyr 15 of Cdc2

Molecular Reproduction and Development

Volumn 74, Issue 10, 2007, Pages 1247-1254

  Zhang, Zhe ^a   Su, Wen Hui ^a   Feng, Chen ^a   Yu, Da Hai ^a   Cui, Cheng ^a   Xu, Xiao Yan ^a   Yu, Bing Zhi ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Cdc2; Embryo; Polo like kinase 1; Scytonemin; Short hairpin RNA

Indexed keywords

CYCLIN DEPENDENT KINASE 1; MESSENGER RNA; POLO LIKE KINASE 1; TYROSINE; TYROSSINE 15; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; INDOLE DERIVATIVE; ONCOPROTEIN; PHENOL DERIVATIVE; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SCYTONEMIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; FEMALE; FERTILIZATION; MALE; MAMMAL; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EMBRYO DEVELOPMENT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PREGNANCY; RNA INTERFERENCE; ZYGOTE;

MAMMALIA;

ANIMALS; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; CELL DIVISION; EMBRYONIC DEVELOPMENT; FEMALE; G2 PHASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INDOLES; MALE; MICE; PHENOLS; PHOSPHORYLATION; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; TYROSINE; ZYGOTE;

EID: 35848940699     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20703     Document Type: Article

References (58)

1. Abrieu A, Brassac T, Galas S, Fisher D, Labbe JC, Doree M. 1998. The polo-like kinase Plx1 is a component of the MPF amplification loop at the G2/M-phase transition of the cell cycle in Xenopus eggs. J Cell Sci 111:1751-1757.
2. Bornslaeger EA, Mattei P, Schultz RM. 1986. Involvement of cAMP-dependent protein kinase and protein phosphorylation in regulation of mouse oocyte maturation. Dev Biol 114:453-462.
3. Dai W, Cogswell JP. 2003. Polo-like kinases and the microtubule organization center: Targets for cancer therapies. Prog Cell Cycle Res 5:327-334.
4. Dai W, Wang Q, Traganos F. 2002. Polo-like kinases and centrosome regulation. Oncogene 21:6195-6200.
5. Dai W, Huang X, Ruan Q. 2003. Polo-like kinases in cell cycle checkpoint control. Front Biosci 8:d1128-d1133.
6. de Carcer G, do Carmo AM, Lallena MJ, Glover DM, Gonzalez C. 2001. Requirement of Hsp90 for centrosomal function reflects its regulation of Polo kinase stability. EMBO J 20:2878-2884.
7. Descombes P, Nigg EA. 1998. The polo-like kinase Plx1 is required for M phase exit and destruction of mitotic regulators in Xenopus egg extracts. EMBO J 17:1328-1335.
8. do Carmo AM, Tavares A, Glover DM. 2001. Polo kinase and Asp are needed to promote the mitotic organizing activity of centrosomes. Nat Cell Biol 3:421-424.
9. Donaldson MM, Tavares AA, Hagan IM, Nigg EA, Glover DM. 2001. The mitotic roles of polo-like kinase. J Cell Sci 114:2357-2358.
10. Dorsett Y, Tuschl T. 2004. siRNAs: Applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3: 318-329.
11. Fan HY, Tong C, Teng CB, Lian L, Li SW, Yang ZM, Chen DY, Schatten H, Sun QY. 2003. Characterization of polo-like kinase-1 in rat oocytes and early embryos implies its functional roles in the regulation of meiotic maturation, fertilization, and cleavage. Mol Reprod Dev 65:318-329.
12. Fischer PM. 2004. The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases. Curr Med Chem Tyr 11:1563-1583.
13. Glover DM, Hagan IM, Tavares AA. 1998. Polo-like kinases: A team that plays throughout mitosis. Genes Dev 12:3777-3787.
14. Golsteyn RM, Mundt KE, Fry AM, Nigg EA. 1995. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J Cell Biol 129:1617-1628.
15. Golsteyn RM, Lane HA, Mundt KE, Arnaud L, Nigg EA. 1996. The family of polo-like kinases. Prog Cell Cycle Res 2:107-114.
16. Hamanaka R, Smith MR, O'Connor PM, Maloid S, Mihalic K, Spivak JL, Longo DL, Ferris DK. 1995. Polo-like kinase is a cell cycleregulated kinase activated during mitosis. J Biol Chem 8:21086-21091.
17. Han SJ, Chen R, Paronetto MP, Conti M. 2005. Wee1B is an oocyte-specific kinase involved in the control of meiotic arrest in the mouse. Curr Biol 15:1670-1676.
18. Hogan B, Constantini LE. 1986. Manipulating the mouse embryos, a laboratory manual. New York: Cold Spring Harbor Laboratory Press. pp 249-256.
19. Inoue D, Sagata N. 2005. The polo-like kinase Plx1 interacts with and inhibits Myt1 after fertilization of Xenopus eggs. EMBO J 24:1057-1067.
20. Jackman M, Lindon C, Nigg EA, Pines J. 2003. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol 5:143-148.
21. Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA. 1991. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 88:4171-4175.
22. Karaiskou A, Cayla X, Haccard O, Jessus C, Ozon R. 1998. MPF amplification in Xenopus oocyte extracts depends on a two-step activation of cdc25 phosphatase. Exp Cell Res 244:491-500.
23. King RW, Jackson PK, Kirshner MW. 1994. Mitosis in transition. Cell 79:563-571.
24. Kumagai A, Dunphy WG. 1996. Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from Xenopus egg extracts. Science 273:1377-1380.
25. Laemmli VK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
26. Lake RJ, Jelinek WR. 1993. Cell cycle- and terminal differentiationassociated regulation of the mouse mRNA encoding a conserved mitotic protein kinase. Mol Cell Biol 13:7793-7801.
27. Lane HA, Nigg EA. 1996. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J Cell Biol 135:1701-1713.
28. Lee KS, Yuan YL, Kuriyama R, Erikson RL. 1995. Plk is an. M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1. Mol Cell Biol 15:7143-7151.
29. Leung GC, Sicheri F. 2003. A polo match for Plk1. Cell 115:3-4.
30. Lieberman J, Song E, Lee SK, Shankar P. 2003. Interfering with disease: Opportunities and roadblocks to harnessing RNA interference. Trends Mol Med 9:397-403.
31. Liu X, Erikson RL. 2002. Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA. Proc Natl Acad Sci USA 99:8672-8676.
32. Liu X, Erikson RL. 2003. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 100:5789-5794.
33. Liu F, Stanton JJ, Wu Z, Piwnica-Worms H. 1997. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol Cell Biol 17:571-583.
34. Mueller PR, Coleman TR, Dunphy WG. 1995a. Cell cycle regulation of a Xenopus Wee1-like kinase. Mol Cell Bio 6:119-134.
35. Mueller PR, Coleman TR, Kumagai A, Dunphy WG. 1995b. Myt1: A membrane - associated inhibitory kinase that phosphorylates Cdc2 on both Threonine-14 and Tyrosine-15. Science 270:86-90.
36. Mundt KE, Golsteyn RM, Lane HA, Nigg EA. 1997. On the regulation and function of human polo-like kinase 1 Plk1: Effects of overexpression on cell cycle progression. Biochem Biophys Res Commun 2392:377-385.
37. Myer DL, Bahassiel M, Stambrook PJ. 2005. The Plk3-Cdc25 circuit. Oncogene 24:299-305.
38. Nigg EA. 1998. Polo-like kinases: Positive regulators of cell division from start to finish. Curr Opin Cell Biol 10:776-783.
39. Nigg EA, Blangy A, Lane HA. 1996. Dynamic changes in nuclear architecture during mitosis: On the role of protein phosphorylation in spindle assembly and chromosome segregation. Exp Cell Res 229: 174-180.
40. Ohkura H, Hagan IM, Glover DM. 1995. The conserved Schizosaccharomyces pombe kinase plo1, required to form a bipolar spindle, the actin ring, and septum, can drive septum formation in G1 and G2 cells. Genes Dev 9:1059-1073.
41. Okano-Uchida T, Okumura E, Iwashita M, Yoshida H, Tachibana K, Kishimoto T. 2003. Distinct regulators for Plk1 activation in starfish meiotic and early embryonic cycles. EMBO J 22:5633-5642.
42. Parke LL, Atherton-Fessler S, Piwnica-Worms H. 1992. p107 wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine15. Proc Natl Acad Sci USA 89:2917-2921.
43. Proteau PJ, Gerwick WH, Garcia-Pichel F, Castenholtz R. 1993. The structure of scytonemin, an ultraviolet sunscreen pigment from the sheaths of cyanobacteria. Experentia 49:825-829.
44. Qian YW, Erikson E, Li C, Maller JL. 1998. Activated polo-like kinase Plx1. is required at multiple points during mitosis in Xenopus laevis. Mol Cell Biol 18:4262-4271.
45. Reagan-Shaw S, Ahmad N. 2005. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: Implications for the treatment of prostate cancer. FASEB J 19:611-613.
46. Roshak AK, Capper EA, Imburgia C, Fornwald J, Scott G, Marshall LA. 2000. The human polo-like kinase, Plk, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase. Cell Signal 12:405-411.
47. Sanchez Y, Bachant J, Wang H, Hu F, Liu D, Tetzlaff M, Elledge SJ. 1999. Control of the DNA damage checkpoint by Chk1 and Rad53 protein kinases through distinct mechanisms. Science 286:1166-1171.
48. Spankuch B, Matthess Y, Knecht R, Zimmer B, Kaufmann M, Strebhardt K. 2004. Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1. J Natl Cancer Inst 96:862-872.
49. Spankuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K. 2002. Effect of RNA silencing of polo-like kinase-1 (Plk1) on apoptosis and spindle formation in human cancer cells. J Natl Cancer Inst 94:1863-1877.
50. Stevenson CS, Capper EA, Roshak AK, Marquez B, Eichman C, Jackson JR, Mattern M, Gerwick WH, Jacobs RS, Marshall LA. 2002a. The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore. J Pharmacol Exp Ther 303:858-866.
51. Stevenson CS, Capper EA, Roshak AK, Marquez B, Grace K, Gerwick WH, Jacobs RS, Marshall LA. 2002b. Scytonemin - a marine natural product inhibitor of kinases key in hyperproliferative inflammatory diseases. Inflamm res 51:112-114.
52. Tong C, Fan H-Y, Lian L, Li S-W, Chen D-Y, Schatten H, Sun Q-Y. 2002. polo-like kinase-1 is a pivotal regulator of microtubule assembly during mouse oocyte meiotic maturation, fertilization, and early embryonic mitosis. Biol Reprod 67:546-554.
53. Toyoshima-Morimoto F, Taniguchi E, Shinya N, Iwamatsu A, Nishida E. 2001. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature 410:215-220.
54. Uchiumi T, Longo DL, Ferris DK. 1997. Cell cycle regulation of the human polo-like kinase Plk promoter. J Biol Chem 4:9166-9174.
55. Watenabe N, Broome M, Honter T. 1995. Regulation of the human Wee1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J 14:1878-1891.
56. Wells NJ, Watanabe N, Tokusumi T, Jiang Wei, Verdecia WA, Hunter T. 1999. The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G2/M progression. J Cell Sci 112:3361-3371.
57. Yuan J, Eckerdt F, Bereiter-Hahn J, Kurunci-Csacsko E, Kaufmann M, Strebhardt K. 2002a. Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1. Oncogene 21:8282-8292.
58. Yuan J, Kramer A, Eckerdt F, Kaufmann M, Strebhardt K. 2002b. Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation. Cancer Res 62:4186-4190.